Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Leprosy [Hansen's disease] |
French
|
Lèpre [maladie de Hansen] |
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | A30-A49 | Other bacterial diseases | |
| 3 | A30 | Leprosy [Hansen's disease] |
| Code | Title | |
|---|---|---|
| A30.0 | Indeterminate leprosy | |
| A30.1 | Tuberculoid leprosy | |
| A30.2 | Borderline tuberculoid leprosy | |
| A30.3 | Borderline leprosy | |
| A30.4 | Borderline lepromatous leprosy | |
| A30.5 | Lepromatous leprosy | |
| A30.8 | Other forms of leprosy | |
| A30.9 | Leprosy, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Chlofazimine |
Clofazimine is an antimycobacterial drug. Clofazimine exerts a slow bactericidal effect on Mycobacterium leprae (Hansen’s bacillus). Clofazimine inhibits mycobacterial growth and binds preferentially to mycobacterial DNA. |
|
| Ethionamide |
Ethionamide is bacteriostatic against M. tuberculosis at therapeutic concentrations, but may be bactericidal at higher concentrations. The exact mechanism of action of ethionamide has not been fully elucidated, but the drug appears to inhibit peptide synthesis in susceptible organisms. Drug resistance develops rapidly when ethionamide is given as monotherapy. |
|
| Minocycline |
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
